From Good To Great: Innovative Biopharmaceutical Manufacturing Is Key

By Dr. Latika Bhonsle-Deeng, Senior Manager Corporate Communication, Rentschler Biopharma SE

The recent past has strongly demonstrated the true potential of biopharmaceuticals, and the coming years promise to further strengthen their global position and reputation. This growth, for the short- and long-term, can best be sustained by advancing innovations in process development and manufacturing.

In pursuit of better treatments to alleviate suffering and improve human lives, biopharmaceuticals have proved to be a game-changer. Fueled by the transition from small molecules to formats with increasing complexity- be it proteins or nucleic acids, and an increase in druggable targets, these biopharmaceuticals are here to stay.

Today, biopharmaceuticals and the manufacturing processes that make them possible, contribute immensely to treating and improving the lives of innumerable patients across the globe. The recent past has shown us how advanced manufacturing can be leveraged to produce new technology like mRNA within cGMP requirements and demanding timelines. Join us in taking a closer look at what this means for scalability and continuous manufacturing.